The Pharmacodynamics of Doripenem Between 4-hour and 1-hour Infusion in Patients With Ventilator-associated Pneumonia

NCT01467648 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Ventilator-Associated Pneumonia

Interventions

DRUG: Doripenem
DRUG: Doripenem

Sponsor

Sutep Jaruratanasirikul

Collaborators

[object Object]